Lifecore’s Withdrawn Intergel Solution Represented 12% Of 2002 Revenues

Lifecore Biomedical and Johnson & Johnson/Ethicon will investigate adverse events involving the firm's Intergel adhesion prevention solution following a voluntary market withdrawal of the device by J&J March 27